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Abstract
Objectives Impulsivity is a vulnerability trait for poor self-
regulation in substance use disorder (SUD). Working memory
(WM) training improves impulsivity and self-regulation in
psychiatric disorders. Here we test WM training in metham-
phetamine use disorder (MUD).
Methods There are 15MUD patients receiving inpatient treat-
ment as usual (TAU) and 20 who additionally completed WM
cognitive training (CT) and 25 healthy controls (HC).
MANCOVA repeated measures analyses examined changes
in impulsivity and self-regulation at baseline and after
4 weeks.
Results Post hoc t tests confirmed that at baseline, feelings of
self-control were significantly lower in the MUD (t = 2.001,
p = 0.05) and depression was higher (t = 4.980, p = 0.001), as
was BIS total impulsivity (t = 5.370, p = 0.001) compared to
the HC group. Total self-regulation score was higher in HC
than MUD patients (t = 5.370, p = 0.001). CT had a 35%
learning rate (R2 = 0.3523, p < 0.05). Compared to follow-
up TAU, follow-up CT group had higher self-reported mood
scores (t = 2.784, p = 0.01) and higher compared to CT base-
line (t = 2.386, p = 0.036). Feelings of self-control were higher
in CT than TAU at follow-up (t = 2.736, p = 0.012) and also
compared to CT baseline (t = 3.390, p = 0.006), lack of plan-
ning significantly improved in CT between baseline and
follow-up (t = 2.219, p = 0.048), as did total impulsivity scores
(t = 2.085, p = 0.048). Measures of self-regulation were im-
proved in the CT group compared to TAU at follow-up, in
total score (t = 2.442, p = 0.038), receiving score (t = 2.314,
p = 0.029) and searching score (t = 2.362, p = 0.027).
Implementing self-regulation was higher in the CT group
compared to TAU (t = 2.373, p = 0.026).
Conclusions WM training may improve control of impulsiv-
ity and self-regulation in people with MUD.
Keywords Workingmemory . Impulsivity . Self-regulation .
Methamphetamine
Introduction
Impulse control disorder is considered to be a characteristic
trait of a variety of psychiatric conditions, in particular
those where failure to resist drives or temptations to per-
form acts become harmful to sufferers and to others
(Atmaca 2014). Impulsivity encompasses ‘knee-jerk’ be-
haviours that are associated with choosing an immediate
over a delayed reward (Hoffman et al. 2006), risky
decision-making (Duarte et al. 2012), memory impairment
and higher levels of depression (Casaletto et al. 2015).
Substance use disorder (SUD) is one example of a psychi-
atric condition that is characterised by deficits in impulse
control, as well as alterations in dopaminergic reward path-
ways in the brain, which has been substantiated by a large
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meta-analysis of 97 studies (Smith et al. 2014). More spe-
cifically, methamphetamine use disorder (MUD) is the
most prevalent SUD in South African (Plüddemann and
Parry 2012) and is associated with impulsive behaviours
and deficits in executive functioning that may underlie the
South African pandemic of HIVand risky sexual behaviour
and other neuropsychological deficits associated with so-
cial problems (Weber et al. 2012; Marquine et al. 2014;
Durvasula and Hinkin 2006). Impulsive behaviour, while
perhaps exacerbated by MUD for example, is also sug-
gested to be an endophenotypic trait—behaviour derived
from genetic susceptibility that predicts vulnerability for
compulsive drug taking (Belin et al. 2015), as well as al-
tered brain processes that underscore a higher likelihood of
relapse after a course of treatment (Everitt 2014).
Given that impulsivity appears to be a trait central to vul-
nerability and persistence of relapse after standard treatment in
those with SUD (Adinoff et al. 2016), it is pertinent to con-
sider adjuncts to treatment that aim to improve brain processes
associated with impulse control and self-regulation. Currently,
standard psychological interventions for SUD are founded in
cognitive behavioural therapy (CBT), which target affect, be-
haviour and cognitions (A-B-C) pertaining to perceptions
about self, the world and others (Magill and Ray 2009).
However, adjunctive treatment that aims to encourage inher-
ent neural plasticity with repetitive and increasingly difficult
cognitive training (Keshavan et al. 2014) may improve
decision-making and self-regulation and therefore the progno-
sis for relapse in those with SUD. For example, the executive
function working memory (WM) is a dynamic neural process
associated with decision-making and improved self-regulation
of cognitive-affective states, and people with SUD are known
to be most susceptible to dysfunction in WM processes
(Bickel et al. 2014). Furthermore, WM training targets
cortico-limbic neural systems associated with cognitive con-
trol that is damaged in those with SUD (Brooks 2016, Brooks
et al. 2016).
In order to test the effects of WM training, particularly in
people with MUD, which can be regarded as the most potent
and prevalent drug of abuse in South Africa, associated with
the contraction and spread of HIV (Plüddemann and Parry
2012), we have recently developed a smartphone-based WM
training intervention in Cape Town, South Africa (Brooks
et al. 2016), to reach out to the need for a low-cost adjunct
to treatment that can target populations whose access to stan-
dard treatment is strained but whose access to a smartphone is
not (Anthes 2016). Moreover, we have demonstrated that
daily patient engagement in our smartphone-based N-back
WM task is easy for clinicians to implement as part of their
standard treatment programme for SUD. For example, the
patients sit in a classroom and complete a 15-min session of
our smartphone intervention twice daily, sending scores back
to researchers/clinicians for tracking. During these sessions,
patients are required to quietly attend to the task without dis-
ruption and touch the screen of their phone when they see the
target letter in a series of letters (see BMaterials and methods^
for more detailed explanation). In this vein, WM training has
been effectively utilised to improve prognosis for other psy-
chiatric populations, particularly in disorders that are comor-
bid with SUD (Akindipe et al. 2014), such as learning diffi-
culties (Peijnenborgh et al. 2016), mood disorders (Meusel
et al. 2013), psychosis (Li et al. 2015) and anxiety (Sari
et al. 2016). In terms of efficacy of WM training for SUD, it
has shown to be an effective strategy to reduce alcohol use by
increasing control over automatic impulses to drink alcohol
(Houben et al. 2011) and to reduce engagement in stimulant
use (Bickel et al. 2011). Furthermore, if some cases of obesity
are regarded as a form of food addiction, then complementary
findings using WM training suggest improvements in weight
control (Verbeken et al. 2013). However, WM training, while
modestly improving cognitive performance in smokers, does
not appear to alter smoking cessation rates (Loughead et al.
2016), and soWM training may be beneficial to some, but not
all SUD patients.
Against this background, no study has yet measured the
effects of WM training on impulse control in MUD, which
may have differential effects on impulse control compared to
other drugs of abuse such as cocaine (Bickel et al. 2011). As
such, WM training may or may not be effective for MUD.
Nevertheless, given that WM training is effective for those
who abuse other stimulants (Bickel et al. 2011), and that we
have recently shown brain changes in those with MUD linked
to changes in impulsivity scores (Brooks et al. 2016), here we
hypothesise that the addition of daily WM cognitive training
alongside treatment as usual (TAU) for patients with MUD
will be associated with improvements on a range of self-
report measures of impulsivity and self-regulation in patients
being treated for MA dependence.
Materials and methods
Participants
See Fig. 1 for CONSORT (Consolidated Standards of
Reporting Trials) recruitment diagram. Sixty MUD individ-
uals (confirmed to be MUD prior to clinical admittance, ab-
stinence was confirmed by clinical screening procedures and
enforced during the clinical program) and 30 healthy controls
(HC) aged between 18 and 50 were initially invited to be
screened to take part in the study, at a local rehabilitation clinic
in Cape Town, South Africa, and at the research offices be-
tween January 2013 and September 2014. At the end of the
study, 35 MUD in-patients were included in data analysis
(n = 7 did not meet the inclusion criteria, n = 8 could not be
scanned in time for follow-up due to scanner closures, n = 4
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were excluded due to emotional difficulties during treatment
as usual and n = 6 patients dropped out and returned home
before the end of the experiment/programme). The mean du-
ration of MUD exposure prior to admittance to the clinic for
the remaining participants who completed the study over
4 weeks was 9.5 years (s.d. = 3.65). According to clinicians,
all patients in the study were abstinent from drug use for at
least 2 weeks before being randomly assigned to one of two
groups. After baseline questionnaire measures were complet-
ed, the MUD baseline participant was given either (a) rehabil-
itative TAU (n = 15) or (b) in addition to TAU 4 weeks of
cognitive training (CT; n = 20) using a WM task. The study
was approved by the University of Cape Town Human
Research Ethics Committee (ref: 554/2012) and adhered to
the guidelines set out in the Declaration of Helsinki. This
was a pilot, exploratory study to examine the effects of WM
training on self-report measures, not clinical outcomes, and
was therefore not a clinical trial or intervention.
Inclusion criteria for the MUD group are as follows:
(a) methamphetamine was the main substance of use;
(b) no DSM history of abusive alcohol use (excluding
infrequent alcohol use or concomitant cannabis/
methaqualone use); (c) no current or previous history
of psychosis as confirmed by clinical staff and screen-
ing questionnaires; (d) no prescribed medication during
the study (e.g. anti-psychotic, anti-depressant, anti-
anxiety medications and/or medications for attention
deficit hyperactivity disorders that may alter cognitive
performance and would be a potential confounding fac-
tor that may alter the effects of WM training [Barch
2004]); (e) negative HIV status; and (f) fluent in
English. Inclusion criteria for the HC group are as fol-
lows: (a) no DSM history of abusive alcohol use (ex-
cluding infrequent alcohol use or concomitant cannabis/
methaqualone use); (b) no current or previous history of
psychiatric disorder (including clinical anxiety, depres-
sion and occasional drug use) as confirmed by screening
questionnaires; (c) no prescribed medication during the
study; (d) negative HIV status; and (e) fluent in
English.
Assessed for eligibility 
(planned 30 per group) 
(n = 90) 
Excluded  
(n = 20) 
Not meeting inclusion criteria 
Alternating first come first allocated 
(n = 70) 
Baseline MUD  
(n=41) 
Completed baseline brain imaging* and questionnaire 
measures 
Afterwards allocated to follow-up group (either CT or TAU) 
by random allocation as they entered the clinic 
A
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o
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Excluded 
(n=4) 
Due to emotional difficulties in the clinic – 
the clinicians felt that the MUD participants 
should not take part in the study 
F
o
ll
o
w
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p
CT (2) Group 
(n=20) 
Completed working memory training 
and 2nd experimental battery on week 6 
of inpatient care. 
Participants who left clinic before 
follow-up (n=4) 
TAU (2) Group 
(n=15) 
Completed treatment as usual and 
2nd experimental battery on week 6 
of inpatient care. 
Participants who left clinic before 
follow-up (n=2) 
Healthy Controls 
(n=25) 
Completed baseline brain 
imaging* and questionnaire 
measures only 
Fig. 1 CONSORT diagram to
describe how healthy controls
(HC) as well as
methamphetamine use disorder
(MUD) participants were
recruited to either the treatment as
usual (TAU) group or the
cognitive training (CT) group.
(Asterisk) Brain scanning data
(structural and functional
magnetic resonance imaging) was
also collected at baseline and
follow-up in HC,MUD, TAU and
CT groups, and this data is
published elsewhere (Brooks
et al. 2016) with further data
currently in preparation
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All participants were compensated with 150 ZAR (South
African currency BRands^ equivalent to approximately $15)
in the form of a supermarket voucher for baseline participation
and 150 ZAR for participation at follow-up.
Clinical setting
MUD patients were recruited from an in-patient rehabilitation
clinic in Cape Town that houses a maximum of 40 male and
female patients at any given time. The rehabilitation program
runs for a total of 8 weeks, during which time patients are
provided with six meals a day (up to 3500 cal), consisting of
a large breakfast, lunch and supper with three small snacks in
between. TAU involves 1-h daily sessions of dialectical be-
havioural therapy (DBT) fromMonday to Friday for 6 weeks,
a total of 30 1-h sessions. DBT, a form of cognitive behav-
ioural therapy (CBT), addresses maladaptive affective re-
sponses and has proven successful in treating SUD. In addi-
tion to DBT, patients attended psycho-education sessions ad-
dressing basic and social skills development and physical ac-
tivities outside. Of note, the first 2 weeks of the program were
regarded as the induction period and so researchers were not
permitted to interview or contact the patients during this time.
Thereafter, researchers were given 4 weeks to conduct data
collection; for TAU, this consisted of baseline and follow-up
questionnaires on 2 days; additionally for CT, this consisted of
daily half-hour cognitive training (excluding weekends). The
final 2 weeks of the 8-week programme were devoted to pre-
paring patients for re-entry to the outside world (and so re-
searchers were again not permitted to contact patients during
this time).
In addition to TAU, during the 4-week data collection pe-
riod, the CT group received training in a classroom at the
clinic, using a computer-based WM task called BCurb Your
Addic t ion (C-Ya)^ ( fo r de ta i l s see h t tp : / /www.
drsamanthabrooks.com/curb-your-addiction) that was
developed by the authors with Fontera Digital Works (www.
fontera.com). Free copies of the software are available upon
request. C-Ya is a modified version of the N-back task (the
modification being a distracting peripheral mosaic to mimic
peripheral distraction in real life), ranging from 0-back to 3-
back. The N-back task was originally introduced by Kirchner
(Kirchner 1958) and requires a response to a specified target
letter as single letters appear on the screen consecutively. In
the present study, the letter ‘X’ was the target for ‘0-back’; for
‘1-back’when the current letter was the same as the ‘1 before’;
for ‘2-back’when the current letter was the same as ‘2 before’
and ‘3 before’ for ‘3-back’. Patients identified targets by
pressing the space bar on the computer keyboard. During the
standard version of the C-Ya task, participants began by com-
pleting 30 min of 0-back and they progress the next day on to
the consecutively higher level after achieving at least 80%
accuracy on the prior level. An 80% threshold was used in
relation to previous data demonstrating the effects of WM
training on neural function; during the previous study, the
highest level of accuracy attained was 80%. Therefore, we
decided to use this as a guideline for our study (Olesen et al.
2003). Accuracy was calculated using the following
algorithm:
[1 − ((number of commissions + number of omissions)/
total possible correct)] × 100 (Miller et al. 2009), where com-
missions were responses to non-target letters; omissions were
failures to respond to a target, and total possible correct was
the total target letters.
Participants were not permitted to progress on to the con-
secutively higher level during the training until they achieved
at least 80% accuracy on the previous level, and due to this,
the task is considered to be adaptive (Keshavan et al. 2014).
Participants in this study were required to engage in the task
five times a week for 4 weeks (maximum 20 sessions). We
calculated the learning rate only in the most difficult 3-back
level, as the previous levels (0-back, 1-back and 2-back had
ceiling effects and limited variance in performance and were
completed during the first induction week of the 4-week train-
ing period). Learning rate was calculated usingWright’s learn-
ing curve equation (Wright 1936):
Y ¼ aX b;
Y the cumulative average time (or cost) per unit
a time (or cost) required to produce the first unit
X the cumulative number of units produced
b slope of the function when plotted on log-log paper
= log of the learning rate/log of 2
We report the learning rate with the regression coefficient,
but only in the participants who, while continuously engaging
in the working memory training, were able to maintain a con-
sistent 3-back performance in the final stages of their training.
Clinical measures
Interview with clinical caseworker at the treatment centre
In the first week, all MUD patients underwent a routine one-to-
one interviewwith a qualified clinician to ascertain diagnosis and
comorbidities, confirming MUD and whether to prescribe med-
ication. Based on the information from clinical interviews and
after permission from the clinical staff, we recruited non-medi-
cated, non-psychotic methamphetamine-dependent, HIV-nega-
tive, currently abstinent in-patients most likely to complete the
full 8-week programme at the clinic.
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Structured Clinical Interview for Diagnosis of Axis I DSM-IV
disorders (First et al. 2002) patient version with psychotic
screen and non-patient version
We selected patients who were identified by clinical staff to
attend an interview with a researcher using the SCID for
DSM-IV, which was conducted at the clinic by a qualified
research scientist. For the HC group, the SCID was conducted
at the university research offices. The SCID included screen-
ing questions for substance abuse (including alcohol and other
drugs), mood, thought, anxiety and general screening ques-
tions. In addition to this, we asked participants to complete the
following self-report measures.
Self-report measures
Hospital Anxiety and Depression Scale (Zigmond and Snaith
1983)
Hospital Anxiety and Depression Scale (HADS) is a 14-item
questionnaire used to assess patients’ levels of anxiety and
depression. Seven of the items relate to depression and 7 to
anxiety. Items are rated on a 4-point scale, with a maximum
score of 21 for both anxiety and depression. A score of 0–7 is
‘normal’, 8–10 is considered ‘borderline’ and 11 or higher is
considered significant.
Barratt Impulsivity Scale (Patton et al. 1995)
Barratt Impulsivity Scale (BIS) is a 30-item questionnaire de-
signed to assess individual levels of impulsivity. Items are
scored on a four-point scale (rarely/never, occasionally, often,
almost always/always) to give six first-order factors (attention,
motor, self-control, cognitive complexity, perseverance and
cognitive instability) and 3-s order factors (attentional, motor
and non-planning) and a total impulsivity score.
Self-Regulation Questionnaire (Brown et al. 1999)
The Self-Regulation Questionnaire (SRQ) is a 63-item ques-
tionnaire designed to assess an individual’s self-regulatory
processes, measuring seven factors of self-regulation: (a) re-
ceiving relevant information, (b) evaluating information and
comparing it to norms, (c) triggering change, (d) searching for
options, (e) formatting a plan, (f) implementing the plan and
(g) assessing the plan’s effectiveness. Items are scored on a
five-point scale (strongly disagree, disagree, unsure, agree,
strongly agree) and participants are asked to respond based
on how well each statement describes them. It has been veri-
fied to give good internal consistency and reliability in a sam-
ple of young adults, particularly the total score.
Trail Making Test (Tombaugh 2004)
The Trail Making Test (TMT) is a paper-based neuropsycho-
logical measure of an individual’s speed of processing, mental
flexibility, executive function (e.g. working memory), visual
searching and scanning abilities. The TMT consists of two
parts: TMT-A and TMT-B. TMT-A requires participants to
draw a line between 25 numbers evenly distributed on a piece
of paper. TMT-B instead requires participants to alternatively
join numbers with letters (e.g. 1, A, 2, B, 3, C). The time taken
to complete the task and the number of errors are recorded. To
account for dexterity, the results from TMT-A are subtracted
from the results of TMT-B to produce a final score.
Visual Analogue Scale (Reips and Funke 2008)
The Visual Analogue Scale (VAS) is a psychometric response
scale, used to assess subjective feelings. In this study, level of
happiness (mood), desire for drug and feelings of self-control
were assessed. Participants responded by placing a mark on a
horizontal line to indicate their current feelings. The left end
point of the line represents low happiness/mood, no desire for
drug and no feelings of self-control, and the right end point
represents high level of happiness/mood, high desire for drug
and high feelings of self-control, respectively. The position of
the mark on the line was measured and transformed into a
percentage for analysis purposes.
Statistical analyses
Normal distribution and homogeneity of variance was
assessed using the Shapiro-Wilk test. A 2 × 2 multivariate
analyses of covariance (MANCOVA), with age and education
as covariates of no interest, was first conducted between group
(HC, baseline MUD) and primary outcome measures: (a) im-
pulsivity (BIS total, VAS desire for drug), (b) self-regulation
(SRQ total, VAS feeling of self-control), and (c) executive
functioning (TMT). We additionally examined anxiety and
depression (HADS, VASmood) as a secondary outcome mea-
sure, given that rates are typically high in patients with MUD
vs. HC prior to treatment. The rationale for conducting this
first MANCOVA analysis was to establish that there were
indeed differences in impulsivity, executive function and
self-regulation scores, as well as mood scores, between base-
line patients and healthy controls.
We conducted a second repeated measures (according to
time) MANCOVA analysis with age and education as covar-
iates of no interest, weighted for duration of drug taking and
assessed significant differences between group (TAU and CT)
and time (baseline, follow-up) on the primary and secondary
outcome measures as above. We chose to include these mea-
sures in our model in order to control for the possibility that
mood (VAS, HADS scores) and executive function
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differences (TMT) would influence the effects of TAU vs. CT
on changes in impulsivity and self-regulation scores.
Additionally, we corrected all analyses for multiple compari-
sons using the Bonferroni method. Following our repeated
measuresMANCOVA analyses, we conducted post hoc t tests
to confirm any significant differences between and within
groups and time points. While total and not subscale scores
on the separate questionnaires were entered into the
MANCOVA analyses (due to their being less power to detect
differences using subscales with scores of smaller ranges), we
additionally conducted post hoc t tests on the subscale scores
as an exploratory measure and report these in the tables.
Results
Demographic and psychological data
See Table 1 for demographic data, Table 2 for mean differ-
ences between and within groups (HC, MUD baseline,
follow-up TAU and CT) and Table 3 for statistical values. In
the CT group, an exponential growth (learning) rate of 35%
(R2 = 0.3523, p < 0.05) was observed using the learning curve
calculation (see BMaterials and methods^, and Fig. 1). While
n = 20 MUD patients successfully completed the cognitive
training over 4 weeks, n = 12 patients were able to sustain a
consistent 3-back performance—we chose to plot the data in
only those who achieved consistent highest level 3-back train-
ing to examine the rate of learning (avoiding the confounding
effect of performance drop-out during training). In other
words, n = 8 participants chose to sporadically return to 2-
back level after various attempts of 3-back, yet still engaged in
training at the lower level (Fig. 2).
MANCOVA and post hoc t test analyses
HC vs. baseline MUD
MANCOVA analyses revealed a significant interaction be-
tween groups (HC, MUD) across the primary outcome mea-
sures (F = 2.365, p = 0.043). Furthermore, examining the
individual primary/secondary outcome measures revealed dif-
ferences between HC and MUD in feelings of self-control
(F = 4.907, p = 0.033), HADS depression (F = 8.252,
p = 0.007), BIS total (F = 13.712, p = 0.001), and SRQ total
(F = 4.902, p = 0.033).
Post hoc t tests confirmed that desire for drug was higher in
MUD patients than controls (t = 3.298, p = 0.002), and that
feeling of self-control was lower in MUD patients than con-
trols (t = 2.001, p = 0.05). Furthermore, depression (but not
anxiety) was higher in the MUD group than controls
(t = 4.980, p = 0.001), as was BIS total impulsivity
(t = 5.370, p = 0.001). Total self-regulation score was higher
in controls than MUD patients (t = 5.370, p = 0.001), and
patients were slower to complete the TrailMaking B executive
function task than controls (t = 3.815, p = 0.001).
Baseline MUD vs. follow-up
Repeated measures MANCOVA analyses revealed no signif-
icant interaction between group (TAU, CT) and time
(baseline, follow-up) (F = 1.038, p = 0.382). However, exam-
ining the between-subjects effects of group and time revealed
separate significant main effects in type of participant (TAU,
CT) and also time (baseline, follow-up) on the total SRQ
(F = 3.020, p = 0.05 and F = 4.732, p = 0.033, respectively)
and a significant difference between time (baseline, follow-
up) on the total BIS (F = 5.246, p = 0.025).
Table 1 Demographic data on
healthy controls, baseline
methamphetamine-using patients,
follow-up treatment as usual
patients and patients who
additionally engaged in cognitive
training
Healthy controls
(n = 25)
All baseline MUD
(n = 41)
TAU group
(n = 15)
CT group
(n = 20)
Age (mean, s.d.) 27.67 (8.714) 29.10 (6.69) 28.11 (6.01) 29.83 (7.32)
Duration drug taking
(years)
– 9.5 (3.63) 10.73 (3.96) 9.42 (4.4)
Ethnicity, n (%)
Black 7 (33) 2 (5) 1 (7) 0 (0)
Mixed race 2 (10) 37 (90) 13 (86) 18 (90)
White 12 (57) 2 (5) 1 (7) 2 (10)
Education, n (%)
No matric 1 (5) 28 (68) 9 (60) 14 (70)
Matric 1 (5) 13 (32) 6 (40) 6 (30)
Undergraduate 12 (57) 0 (0) 0 (0) 0 (0)
Honours 4 (19) 0 (0) 0 (0) 0 (0)
PhD 3 (14) 0 (0) 0 (0) 0 (0)
s.d. standard deviation, MUD methamphetamine use disorder, TAU treatment as usual, CT cognitive training
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Post hoc t tests revealed a significantly higher percentage
mood score (as measured by the VAS) in CT compared to
TAU group at follow-up (t = 2.784, p = 0.01) and significantly
higher at follow-up CT compared to baseline CT (t = 2.386,
p = 0.036). Similarly, significantly higher percentage feeling
of self-control was observed in the CT compared to the TAU
group at follow-up (t = 2.736, p = 0.012) and also significantly
higher at follow-up CT compared to baseline CT (t = 3.390,
p = 0.006). In terms of measures of executive function, a
significantly faster time to complete the Trail Making Task
(B minus A) was observed in the TAU group at follow-up
compared to TAU at baseline (t = 2.508, p = 0.026), an effect
that was not observed in the CT group. Significantly improved
sense of lack of self-control (as measured by BIS self-control)
was observed at follow-up compared to baseline in both the
TAU (t = 2.566, p = 0.022) and CT (t = 2.298, p = 0.042)
groups. Also demonstrated by the BIS, a significantly lower
level of cognitive instability (t = 2.722, p = 0.012) and second-
order (lack of) attention (t = 2.199, p = 0.037) was observed in
the TAU group at follow-up compared to baseline, whereas a
significantly improved lack of planning was observed in the
CT group at follow-up compared to baseline (t = 2.219,
p = 0.048). Finally, total BIS was significantly better in the
follow-up CT compared to the baseline CT group (t = 2.085,
p = 0.048). The TAU group had significantly improved anx-
iety scores at follow-up compared to baseline (t = 0.242,
p = 0.023). Finally, on the SRQ, a significantly higher total
score (t = 2.442, p = 0.038), receiving score (t = 2.314,
p = 0.029) and searching score (t = 2.362, p = 0.027) were
observed in the CT compared to the TAU group at follow-up.
Furthermore, the SRQ planning score was significantly higher
in the follow-up compared to baseline TAU group (t = 2.227,
p = 0.046), and finally, SRQ implementing was significantly
higher in the CT group compared to the TAUgroup at baseline
(t = 2.373, p = 0.026).
Discussion
To our best knowledge, we have conducted the first pilot study
in patients already in standard treatment for methamphetamine
use disorder (MUD) to examine whether 4 weeks of cognitive
training (CT) using a progressively difficult adaptive working
memory (WM) task alters patients’ self-reports of impulsivity
and self-regulation in relation to a healthy group with no his-
tory of MUD.We show that the CT group who engaged in the
highest level of training had a learning effect of 35% between
baseline and after 4 weeks of WM training, which coincided
with changes in self-reported impulsivity and self-regulation
scores when comparing patient baseline to follow-up.
Our preliminary findings are in line with previous studies
advocating WM training as a useful adjunct to treatment to
improve cognitions in psychiatric disorders. For example, a
recent meta-analysis in people with intellectual disabilities
showed improvements in memory with a small effect size
(Danielsson et al. 2015). Another meta-analysis of WM train-
ing showed WM improvements in young adults (a demo-
graphic most susceptible to engaging in substance use) that
were associated with long-term cognitive improvements
(Peijnenborgh et al. 2016). Moreover, WM training in chil-
dren with learning difficulties has been linked to improve-
ments in impulsivity, self-regulation and attention deficits
Table 2 Psychological variables
that were analysed in the
MANCOVA
Means (standard deviation)
Variables Healthy
controls
(n = 21)
All baseline
MA (n = 41)
Baseline
TAU
(n = 17)
Baseline
CT
(n = 24)
Follow-up
TAU
(n = 15)
Follow-up
CT (n = 20)
VAS mood (%) 64 (13) 59 (30) 57 (36) 62 (27) 60 (29) 82 (19)
VAS desire for
drug (%)
4 (6) 19 (24) 20 (28) 20 (22) 17 (17) 14 (22)
VAS feelings of
self-control
(%)
83 (15) 69 (21) 66 (24) 72 (20) 77 (19) 92 (11)
HADS anxiety 7 (3) 7 (2) 8 (1) 7 (2) 7 (3) 6 (2)
HADS
depression
2 (2) 6 (3) 6 (2) 5 (4) 6 (8) 3 (3)
Trail Making
response time
(B-A)
34 (16) 62 (51) 53 (51) 69 (51) 42 (36) 44 (30)
BIS total 53 (9) 66 (10) 68 (8) 64 (11) 67 (13) 60 (11)
SRQ total 233 (23) 227 (23) 221 (15) 229 (29) 220 (18) 246 (27)
s.d. standard deviation,MUDmethamphetamine use disorder, TAU treatment as usual,CTcognitive training, VAS
Visual Analogue Scale, HADS Hospital Anxiety and Depression Scale, BIS Barratt Impulsivity Score, SRQ Self-
Regulation Questionnaire
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(Klingberg et al. 2005; Re et al. 2015). Another recent large
meta-analysis of children and adults both with and without
attention deficit hyperactivity disorder (ADHD) has shown
WM training to improve levels of inattention in daily life that
appears to be sustainable regardless of diagnosis (Spencer-
Smith and Klingberg 2015). Furthermore, another meta-
analysis has shown that CT is linked to improvements in
levels of depression and everyday functioning (Motter et al.
2016), which is important to consider given that depression is
a well-known comorbidity with SUD (McKetin et al. 2016).
Considering whether WM training improves levels of im-
pulsivity in patients with SUD specifically—and our prelimi-
nary findings on self-reported levels of impulsivity suggest
that it might—is in line with previous work showing that
WM training reduces delay discounting (a measure of impul-
sivity or ability to delay gratification) in individuals with SUD
(Bickel et al. 2011). However, the previous study mainly in-
cluded people with cocaine dependence rather than, as in our
study, only those with MUD, and the abuse of different
substances may damage the brain in different ways.
Similarly, other studies of WM training in psychiatric popula-
tions that are often comorbid with SUD (Akindipe et al. 2014),
such as learning difficulties (Peijnenborgh et al. 2016), mood
disorder (Meusel et al. 2013), psychosis (Li et al. 2015) and
anxiety (Sari et al. 2016), show improvements to clinical mea-
sures post-intervention. Thus, while our findings are small and
preliminary, our first-of-its-kind pilot study suggests that WM
training is also beneficial to patients in treatment for MUD.
Our findings are also in line with thinking in the field thatWM
training may provide benefit to people in treatment for addic-
tion (Bickel et al. 2014).
In terms of the method by which we delivered WM train-
ing, a recent review has summarised how computerised WM
training, which was used during this study, has been effective
at improving relapse rates for SUD, by providing better acces-
sibility to portable devices, improved information capture and
adaptability in individual ability in order to engage WM ca-
pacity at the highest level (Bickel et al. 2014). In that respect,
Table 3 T test analyses between patient groups in the main clinical variables (subscales on questionnaire measures were not examined due to lack of
power)
p value
T statistic
(Cohen’s d effect size)
Baseline TAU
vs. baseline CT
Follow-up TAU
vs. follow-up CT
Baseline TAU vs.
follow-up TAU
Baseline CT vs.
follow-up CT
Baseline MUD vs.
follow-up MUD
Baseline MUD
vs. follow-up
TAU
Baseline MUD
vs. follow-up CT
Mood (%) 0.312
1.037
(0.22)
0.024
2.446
(0.92)
0.347
0.968
(0.97)
0.018
2.546
(0.91)
0.034
2.196
(0.49)
0.465
0.741
(0.04)
0.011
2.689
(0.92)
Desire for drug
(%)
0.498
0.691
(0)
0.371
0.915
(0.15)
0.410
0.844
(0.13)
0.069
1.904
(0.27)
0.207
1.283
(0.20)
0.379
0.894
(0.13)
0.251
1.169
(0.15)
Feelings of
self-control
(%)
0.269
1.138
(0.27)
0.021
2.510
(0.96)
0.166
1.446
(0.57)
0.003
3.315
(1.27)
0.005
2.964
(0.86)
0.170
1.407
(0.4)
0.001
3.616
(0.96)
HADS anxiety 0.075
1.880
(0.75)
0.159
1.464
(0.45)
0.177
1.408
(0.44)
0.188
1.358
(0.31)
0.091
1.730
(0.34)
0.438
0.786
(0.06)
0.052
2.015
(0.45)
HADS
depression
0.144
1.520
(0.52)
0.050
2.088
(0.8)
0.386
0.889
(0.13)
0.025
2.406
(0.54)
0.322
1.003
(0.14)
0.185
1.356
(0.33)
0.017
2.523
(0.8)
Trail Making
response time
(B-A)
0.246
1.195
(0.31)
0.439
0.790
(0.07)
0.231
1.242
(0.27)
0.385
0.885
(0.63)
0.06
1.943
(0.47)
0.140
1.517
(0.47)
0.131
1.549
(0.07)
BIS total 0.216
1.277
(0.37)
0.079
1.851
(0.64)
0.466
0.747
(0.03)
0.048
2.085
(0.44)
0.107
1.650
(0.25)
0.351
0.947
(0.15)
0.056
1.985
(0.64)
SRQ total 0.226
1.249
(0.41)
0.005
3.164
(1.53)
0.239
1.221
(0.37)
0.096
1.735
(0.71)
0.212
1.268
(0.26)
0.140
1.517
(0.51)
0.018
2.496
(1.53)
TAU treatment as usual, CT cognitive training,MUD methamphetamine use disorder, HADS Hospital Anxiety and Depression, BIS Barratt Impulsivity
Scale, SRQ Self-Regulation Questionnaire
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we adopted smartphone-based delivery of our computerised
WM training, in line with recent reports that in low-middle
income countries such as South Africa, smartphones are use-
ful at reaching patient populations whose access to treatment
facilities is often hampered, but whose access to a smartphone
is not (Anthes 2016). In addition, the effects of WM training
for those with SUD are suggested to work by harnessing in-
herent neuroplasticity (e.g. neurobiological learning processes
(Lewis 2016)) associated with improvements in the neuropsy-
chological ability to self-regulate to achieve future goals, to
control one’s attention and to protect future goals from inter-
ferences such as immediate desires and craving (Hofmann
et al. 2012).
Sex and gender difference must also be considered in the
context of our data, given that in Cape Town, males are more
likely than females to present to treatment services with MUD
(Weybright et al. 2016) and that we only measured males
during this pilot study. However, in light of the evidence
documenting sex differences in those with substance and be-
havioural addictions (Sanchis-Segura and Becker 2016), the
impact of gender differences on the outcome of WM training
is of importance. For example, currently abstinent males, and
not females, who engage in recreational use of cocaine show
differences in neurocognitive functioning, such as poorer at-
tention and greater verbal recognition memory (Rahman and
Clarke 2005). Additionally, in terms of behavioural addic-
tions, such as compulsive shopping, women as opposed to
men show activation of an avoidance coping mechanism
(mood compensation) that is secondary to irrational cogni-
tions, which mediates the link between compulsive buying
and psychological distress (Ching et al. 2016). Furthermore,
given the evidence that sex and gender differences modulate
drug consumption as well as the transition towards drug-
promoted pathological states (Sanchis-Segura and Becker
2016), it is conceivable that WM training will influence un-
derlying brain processes differently in men and women. For
example, the pharmacological impact of MUD on levels of
impulsivity and compulsivity is determined by differences in
various sex-related factors, such as neuromodulators (e.g. go-
nadal hormones) that influence neuroplasticity in relevant
neural circuits between males and females (Fattore and
Melis 2016). Similarly, given the influences of such sex dif-
ferences, males and females may respond differently to novel
treatments, in that males may respond better to cognitive ad-
juncts (e.g. WM training) whereas females may respond better
to behavioural adjuncts (e.g. exercise regimes) (Carroll and
Smethells 2016). Future research should provide adequate
statistical power to compare males and females to progress
the field of WM training in those with addiction disorders.
This pilot study, the first to examine whether WM training
alters self-reported impulsivity and self-regulation scores in
those being treated for MA use, has some limitations that
deserve emphasis. Firstly, self-report measures alone are not
sufficient to gauge changes in impulsivity and self-regulation,
and clinician or other objectively rated scales are also needed.
For example, the go/no-go and stop signal tasks are often used
as objective measures of impulsivity/behavioural inhibition
(Smith et al. 2014). It would also have been useful to collect
subjectivemeasures of the cognitive training process, to gauge
whether the patients felt any benefits of WM training during
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Fig. 2 Graph to illustrate the
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Wright’s learning curve equation
(Wright 1936). CT cognitive
training; individual lines on graph
represent individual subjects who
were in the CT group; x axis
number of days engaging in 3-
back, y axis percentage correctly
identified targets. Of note, only
n = 12 participants were included
in this calculation for consistency,
because n = 8 participants, while
they did engage in 4 weeks of
cognitive training, did not
consistently engage in 3-back but
rather sporadic 2-back and 3-back
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their daily schedule. Furthermore, given various constraints,
we were unable to increase the number of participants mea-
sured and unfortunately 11 dropped out during their standard
treatment. Moreover, we did not include measures of stress
levels throughout the study, which may impede progress dur-
ing TAU or CT, although scores on the HADS have been
shown to be significantly related to clinical stress measures
(Luckett et al. 2010; Iani et al. 2014). Another limitation is that
we only used one cognitive measure to examine cognitive
impairment across the groups (e.g. the TMT), and future stud-
ies would do well to conduct more extensive testing at base-
line of cognitive function as a potential confound to engage-
ment in cognitive training. Additionally, we did not incorpo-
rate a non-training computer-based control session into our
paradigm, and so while we can compare TAU to those who
also received adjunctive CT, it cannot be fully determined that
our preliminary findings are due entirely to the WM training,
although our findings are in line with previous research in
other cohorts. Previous studies have given training over longer
periods and observed more significant results. Nevertheless,
our preliminary data of the effects of WM training on self-
report measures warrants future exploration in terms of offer-
ing training as a formal intervention, particularly as other re-
searchers examining different cohorts with impulse control
deficits (e.g. ADHD, alcoholism, cocaine use) have shown
positive effects of WM training (Klingberg et al. 2005;
Houben et al. 2011; Bickel et al. 2011).
Conclusions
This pilot study is the first to suggest that 4 weeks of WM
training could be a promising adjunct for patients receiving
treatment for methamphetamine use disorder. While we did
not conduct a formal clinical trial and that we only measured
self-reported measures, it may still be the case that WM train-
ing when offered as an adjunct to treatment as usual can re-
duce clinical symptoms of impulsivity and improve self-
regulation in methamphetamine users, particularly those most
vulnerable to relapse.
Compliance with ethical standards The study was approved by the
University of Cape Town Human Research Ethics Committee (ref: 554/
2012) and adhered to the guidelines set out in the Declaration of Helsinki.
This was a pilot, exploratory study to examine the effects of WM training
on self-report measures, not clinical outcomes, and was therefore not a
clinical trial or intervention.
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